KYNDAL STEVENS: Open Payments
NPI 1083250757 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 85 payments from 18 companies in 2025. Trend: 2023 $1,467 · 2024 $1,882 · 2025 $1,886
Food & beverage: $1,786Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $263 |
| Novo Nordisk Inc | 13 | $201 |
| PFIZER INC. | 10 | $192 |
| ABBVIE INC. | 7 | $192 |
| Astellas Pharma US Inc | 3 | $154 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $148 |
| Lilly USA, LLC | 6 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $104 |
| Sage Therapeutics, LLC | 5 | $95 |
| Organon LLC | 4 | $90 |
Products named: VRAYLAR, BREZTRI, NURTEC ODT, BIJUVA, CAPLYTA, MOUNJARO, ZURZUVAE, FARXIGA.
Industry payments across OK — which companies pay providers there.
